Cargando…

Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study

PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ho Yeon, Park, Sunmin, Shin, Beomsu, Lee, Ji-Ho, Lee, Seok Jeong, Lee, Myoung Kyu, Lee, Won-Yeon, Yong, Suk Joong, Kim, Sang-Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267186/
https://www.ncbi.nlm.nih.gov/pubmed/30479080
http://dx.doi.org/10.4168/aair.2019.11.1.90
_version_ 1783376009539616768
author Jung, Ho Yeon
Park, Sunmin
Shin, Beomsu
Lee, Ji-Ho
Lee, Seok Jeong
Lee, Myoung Kyu
Lee, Won-Yeon
Yong, Suk Joong
Kim, Sang-Ha
author_facet Jung, Ho Yeon
Park, Sunmin
Shin, Beomsu
Lee, Ji-Ho
Lee, Seok Jeong
Lee, Myoung Kyu
Lee, Won-Yeon
Yong, Suk Joong
Kim, Sang-Ha
author_sort Jung, Ho Yeon
collection PubMed
description PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused by antituberculosis drugs. METHODS: The electronic medical records of a cohort consisting of adult patients diagnosed with tuberculosis between July 2006 and June 2010 were reviewed and retrospectively inspected. We searched the surveillance system for adverse drug reactions and the electronic medical records to identify patients who reported severe cutaneous adverse reactions to antituberculosis drugs. These patients were then re-assessed using a European Registry of Severe Cutaneous Adverse Reactions to Drugs and Collection of Biological Samples (RegiSCAR) scoring system. Clinical characteristics, including the symptoms and latency of DRESS syndrome, the therapeutic dosage and period of steroids, and the final duration of tuberculosis therapy, were examined. RESULTS: Of the 1,253 adult patients with tuberculosis receiving antituberculosis drugs, 15 were identified as potential cases of DRESS syndrome (prevalence of 1.2%). Ethambutol was the most frequently used drug (53.5%), followed by rifampicin (26.7%), pyrazinamide (20.0%), streptomycin (13.3%), and isoniazid (6.7%). The median latency after day 1 of antituberculosis medication was 42 days. The median daily dose of steroids, expressed in prednisone-equivalent units, was 33-mg/day, and the median dosing period was 14 days. The duration of tuberculosis treatment was 76 days longer than the standard treatment period of 180 days. There was a significant difference in the peak eosinophil counts of DRESS syndrome patients according to RegiSCAR scores. Moreover, there was a significant quantitative correlation between the RegiSCAR score and peak eosinophil count. A negative correlation was also found between the RegiSCAR score and latency. CONCLUSIONS: This study confirmed the prevalence of DRESS syndrome in a cohort of adult patients with tuberculosis.
format Online
Article
Text
id pubmed-6267186
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
record_format MEDLINE/PubMed
spelling pubmed-62671862019-01-01 Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study Jung, Ho Yeon Park, Sunmin Shin, Beomsu Lee, Ji-Ho Lee, Seok Jeong Lee, Myoung Kyu Lee, Won-Yeon Yong, Suk Joong Kim, Sang-Ha Allergy Asthma Immunol Res Original Article PURPOSE: Although there have been reported cases of drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome caused by antituberculosis drugs, there has been no research to examine its prevalence. This study assessed the prevalence and clinical characteristics of DRESS syndrome caused by antituberculosis drugs. METHODS: The electronic medical records of a cohort consisting of adult patients diagnosed with tuberculosis between July 2006 and June 2010 were reviewed and retrospectively inspected. We searched the surveillance system for adverse drug reactions and the electronic medical records to identify patients who reported severe cutaneous adverse reactions to antituberculosis drugs. These patients were then re-assessed using a European Registry of Severe Cutaneous Adverse Reactions to Drugs and Collection of Biological Samples (RegiSCAR) scoring system. Clinical characteristics, including the symptoms and latency of DRESS syndrome, the therapeutic dosage and period of steroids, and the final duration of tuberculosis therapy, were examined. RESULTS: Of the 1,253 adult patients with tuberculosis receiving antituberculosis drugs, 15 were identified as potential cases of DRESS syndrome (prevalence of 1.2%). Ethambutol was the most frequently used drug (53.5%), followed by rifampicin (26.7%), pyrazinamide (20.0%), streptomycin (13.3%), and isoniazid (6.7%). The median latency after day 1 of antituberculosis medication was 42 days. The median daily dose of steroids, expressed in prednisone-equivalent units, was 33-mg/day, and the median dosing period was 14 days. The duration of tuberculosis treatment was 76 days longer than the standard treatment period of 180 days. There was a significant difference in the peak eosinophil counts of DRESS syndrome patients according to RegiSCAR scores. Moreover, there was a significant quantitative correlation between the RegiSCAR score and peak eosinophil count. A negative correlation was also found between the RegiSCAR score and latency. CONCLUSIONS: This study confirmed the prevalence of DRESS syndrome in a cohort of adult patients with tuberculosis. The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2018-10-10 /pmc/articles/PMC6267186/ /pubmed/30479080 http://dx.doi.org/10.4168/aair.2019.11.1.90 Text en Copyright © 2019 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Jung, Ho Yeon
Park, Sunmin
Shin, Beomsu
Lee, Ji-Ho
Lee, Seok Jeong
Lee, Myoung Kyu
Lee, Won-Yeon
Yong, Suk Joong
Kim, Sang-Ha
Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title_full Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title_fullStr Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title_full_unstemmed Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title_short Prevalence and Clinical Features of Drug Reactions With Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculosis Drugs: A Retrospective Cohort Study
title_sort prevalence and clinical features of drug reactions with eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: a retrospective cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267186/
https://www.ncbi.nlm.nih.gov/pubmed/30479080
http://dx.doi.org/10.4168/aair.2019.11.1.90
work_keys_str_mv AT junghoyeon prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT parksunmin prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT shinbeomsu prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT leejiho prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT leeseokjeong prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT leemyoungkyu prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT leewonyeon prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT yongsukjoong prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy
AT kimsangha prevalenceandclinicalfeaturesofdrugreactionswitheosinophiliaandsystemicsymptomssyndromecausedbyantituberculosisdrugsaretrospectivecohortstudy